Your browser is no longer supported

For the best possible experience using our website we recommend you upgrade to a newer version or another browser.

Your browser appears to have cookies disabled. For the best experience of this website, please enable cookies in your browser

We'll assume we have your consent to use cookies, for example so you won't need to log in each time you visit our site.
Learn more

NICE releases draft guidance on constipation in women

  • Comment

NICE has published draft guidance recommending prucalopride (Resolor, Movetis) as an option for the treatment of chronic constipation in women.

However, NICE has provisionally ruled that prucalopride should only be considered for women who have tried at least two different types of laxative and lifestyle changes for at least six months, but have not had relief from constipation.

A consultation on the guidance will close on 24 August with the final guidelines expected to be published in December.

  • Comment

Have your say

You must sign in to make a comment

Please remember that the submission of any material is governed by our Terms and Conditions and by submitting material you confirm your agreement to these Terms and Conditions. Links may be included in your comments but HTML is not permitted.

Related Jobs